525 related articles for article (PubMed ID: 30305310)
41. Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus.
Sim JH; Himmel NJ; Redd SK; Pulous FE; Rogers RT; Black LN; Hong SM; von Bergen TN; Blount MA
PLoS One; 2014; 9(7):e101753. PubMed ID: 25006961
[TBL] [Abstract][Full Text] [Related]
42. Changes of rat kidney AQP2 and Na,K-ATPase mRNA expression in lithium-induced nephrogenic diabetes insipidus.
Laursen UH; Pihakaski-Maunsbach K; Kwon TH; Østergaard Jensen E; Nielsen S; Maunsbach AB
Nephron Exp Nephrol; 2004; 97(1):e1-16. PubMed ID: 15153756
[TBL] [Abstract][Full Text] [Related]
43. Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.
Ando F; Sohara E; Morimoto T; Yui N; Nomura N; Kikuchi E; Takahashi D; Mori T; Vandewalle A; Rai T; Sasaki S; Kondo Y; Uchida S
Nat Commun; 2016 Nov; 7():13636. PubMed ID: 27892464
[TBL] [Abstract][Full Text] [Related]
44. Lithium Chloride and GSK3 Inhibition Reduce Aquaporin-2 Expression in Primary Cultured Inner Medullary Collecting Duct Cells Due to Independent Mechanisms.
Kaiser M; Edemir B
Cells; 2020 Apr; 9(4):. PubMed ID: 32340354
[TBL] [Abstract][Full Text] [Related]
45. Obestatin ameliorates water retention in chronic heart failure by downregulating renal aquaporin 2 through GPR39, V2R and PPARG signaling.
Bao LZ; Shen M; Qudirat H; Shi JB; Su T; Song JW; Wang ZK; Zhao XX; Jing Q; Zheng X; Guo ZF
Life Sci; 2019 Aug; 231():116493. PubMed ID: 31153818
[TBL] [Abstract][Full Text] [Related]
46. Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport.
Arystarkhova E; Bouley R; Liu YB; Sweadner KJ
PLoS One; 2017; 12(11):e0188006. PubMed ID: 29155857
[TBL] [Abstract][Full Text] [Related]
47. HDAC3 inhibition improves urinary-concentrating defect in hypokalaemia by promoting AQP2 transcription.
Xu L; Xie H; Hu S; Zhao X; Han M; Liu Q; Feng P; Wang W; Li C
Acta Physiol (Oxf); 2022 Apr; 234(4):e13802. PubMed ID: 35178888
[TBL] [Abstract][Full Text] [Related]
48. Arginase-II negatively regulates renal aquaporin-2 and water reabsorption.
Huang J; Montani JP; Verrey F; Feraille E; Ming XF; Yang Z
FASEB J; 2018 Oct; 32(10):5520-5531. PubMed ID: 29718707
[TBL] [Abstract][Full Text] [Related]
49. Nuclear Receptor Regulation of Aquaporin-2 in the Kidney.
Zhang XY; Wang B; Guan YF
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409611
[TBL] [Abstract][Full Text] [Related]
50. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
[TBL] [Abstract][Full Text] [Related]
51. Sorting Nexin 27 Regulates the Lysosomal Degradation of Aquaporin-2 Protein in the Kidney Collecting Duct.
Choi HJ; Jang HJ; Park E; Tingskov SJ; Nørregaard R; Jung HJ; Kwon TH
Cells; 2020 May; 9(5):. PubMed ID: 32413996
[TBL] [Abstract][Full Text] [Related]
52. RNA-Seq and protein mass spectrometry in microdissected kidney tubules reveal signaling processes initiating lithium-induced nephrogenic diabetes insipidus.
Sung CC; Chen L; Limbutara K; Jung HJ; Gilmer GG; Yang CR; Lin SH; Khositseth S; Chou CL; Knepper MA
Kidney Int; 2019 Aug; 96(2):363-377. PubMed ID: 31146973
[TBL] [Abstract][Full Text] [Related]
53. Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion.
Yang B; Zhao D; Qian L; Verkman AS
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F465-72. PubMed ID: 16434568
[TBL] [Abstract][Full Text] [Related]
54. Fluvastatin modulates renal water reabsorption in vivo through increased AQP2 availability at the apical plasma membrane of collecting duct cells.
Procino G; Barbieri C; Carmosino M; Tamma G; Milano S; De Benedictis L; Mola MG; Lazo-Fernandez Y; Valenti G; Svelto M
Pflugers Arch; 2011 Nov; 462(5):753-66. PubMed ID: 21858457
[TBL] [Abstract][Full Text] [Related]
55. Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.
Sohara E; Rai T; Yang SS; Uchida K; Nitta K; Horita S; Ohno M; Harada A; Sasaki S; Uchida S
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14217-22. PubMed ID: 16968783
[TBL] [Abstract][Full Text] [Related]
56. Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation.
Miyazaki-Anzai S; Masuda M; Kohno S; Levi M; Shiozaki Y; Keenan AL; Miyazaki M
J Lipid Res; 2018 Sep; 59(9):1709-1713. PubMed ID: 29976576
[TBL] [Abstract][Full Text] [Related]
57. Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis.
Miyazaki-Anzai S; Masuda M; Levi M; Keenan AL; Miyazaki M
PLoS One; 2014; 9(9):e108270. PubMed ID: 25237811
[TBL] [Abstract][Full Text] [Related]
58. Reciprocal regulation of aquaporin-2 abundance and degradation by protein kinase A and p38-MAP kinase.
Nedvetsky PI; Tabor V; Tamma G; Beulshausen S; Skroblin P; Kirschner A; Mutig K; Boltzen M; Petrucci O; Vossenkämper A; Wiesner B; Bachmann S; Rosenthal W; Klussmann E
J Am Soc Nephrol; 2010 Oct; 21(10):1645-56. PubMed ID: 20724536
[TBL] [Abstract][Full Text] [Related]
59. Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration.
Luo R; Hu S; Liu Q; Han M; Wang F; Qiu M; Li S; Li X; Yang T; Fu X; Wang W; Li C
FASEB J; 2019 Jan; 33(1):469-483. PubMed ID: 30036087
[TBL] [Abstract][Full Text] [Related]
60. Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist.
Rizzo G; Passeri D; De Franco F; Ciaccioli G; Donadio L; Rizzo G; Orlandi S; Sadeghpour B; Wang XX; Jiang T; Levi M; Pruzanski M; Adorini L
Mol Pharmacol; 2010 Oct; 78(4):617-30. PubMed ID: 20631053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
